Supernus Pharmaceuticals (SUPN) presented its post-patent loss growth strategy at the Wells Fargo 21st Annual Healthcare Conference. The company detailed its plans for sustained expansion following key patent expirations.
Supernus Pharmaceuticals Outlines Growth Strategy Post-Patent Expirations at Wells Fargo Conference
SUPNPharmaceuticalsHealthcare SectorPatent ExpiryGrowth Strategy
